FDA approves anxiety drug by Hi-Tech Pharmacal

The U.S. Food and Drug Administration has approved Hi-Tech Pharmacal’s generic version of Roxane Laboratories’ Lorazepam Intensol oral concentrate used to treat anxiety. The agency approved Hi-Tech’s Abbreviated New Drug Application. Hi-Tech plans to launch the product by May. Related stories Roxane’s Lorazepam Intensol oral concentrate generated $10 million in branded and generic sales in ...